(VIANEWS) – Republic Bancorp (RBCAA), Allied Motion Technologies (AMOT), Coda Octopus Group (CODA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Republic Bancorp (RBCAA)
20.2% sales growth and 10.78% return on equity
Republic Bancorp, Inc., a financial holding company, provides various banking products and services in the United States. It operates in five segments: Traditional Banking, Warehouse, Mortgage Banking, Tax Refund Solutions, and Republic Credit Solutions. The company accepts demand, money market accounts, savings, individual retirement accounts, time, brokered, and other certificates of deposit. Its loan products include residential real estate, commercial real estate, construction and land development, home improvement and home equity, secured and unsecured personal, and aircraft loans. The company also offers credit cards; title insurance and other financial products and services; and memory banking, private banking, lockbox processing, remote deposit capture, business online banking, account reconciliation, automated clearing house processing, and internet and mobile banking services. In addition, it provides short-term and revolving credit facilities to mortgage bankers; tax refund solutions, which facilitate the receipt and payment of federal and state tax refund products through third-party tax preparers and tax-preparation software providers; and general purpose reloadable prepaid cards through third party service providers. Further, the company offers consumer credit products; and property and casualty insurance products. As of January 28, 2022, it operated 42 full-service banking centers. Republic Bancorp, Inc. was incorporated in 1974 and is headquartered in Louisville, Kentucky.
Earnings Per Share
As for profitability, Republic Bancorp has a trailing twelve months EPS of $4.59.
PE Ratio
Republic Bancorp has a trailing twelve months price to earnings ratio of 9.69. Meaning, the purchaser of the share is investing $9.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.78%.
2. Allied Motion Technologies (AMOT)
18.8% sales growth and 8.39% return on equity
Allied Motion Technologies Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems that are used in a range of industries worldwide. The company offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers. It also provides electric steering actuators, steering motors, electrohydraulic pump motor, steering wheel sensor, traction wheel drives, power differentiating transaxles, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, as well as authorized manufacturers' representatives, agents, and distributors. Allied Motion Technologies Inc. was incorporated in 1962 and is headquartered in Amherst, New York.
Earnings Per Share
As for profitability, Allied Motion Technologies has a trailing twelve months EPS of $0.95.
PE Ratio
Allied Motion Technologies has a trailing twelve months price to earnings ratio of 42.9. Meaning, the purchaser of the share is investing $42.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.39%.
Volume
Today’s last reported volume for Allied Motion Technologies is 34417 which is 46.52% below its average volume of 64365.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 150% and 137.5%, respectively.
Sales Growth
Allied Motion Technologies’s sales growth is 30.4% for the present quarter and 18.8% for the next.
3. Coda Octopus Group (CODA)
16.1% sales growth and 10.19% return on equity
Coda Octopus Group, Inc., together with its subsidiaries, develops and sells underwater technologies and equipment for imaging, mapping, defense, and survey applications in the Americas, Europe, Australia, Asia, the Middle East, and Africa. The company operates through two segments, Marine Engineering Business and Marine Technology Business. It offers CodaOctopus GeoSurvey data acquisition and interpretation software; acquisition products, such as hardware and software solutions for field acquisition of sidescan sonar and sub-bottom profiler; and CodaOctopus GeoSurvey productivity suite of software that automates the tasks of analyzing, annotating, and mosaicing complex data sets. The company also provides motion sensing products, which include Octopus F180 and F170 products that bring accurate positioning and motion data into offshore conditions for marine survey applications. In addition, it offers CodaOctopus underwater inspection system; 3D MATT, a multiple automatic target tracking solution used for diver tracking; and Echoscope and construction monitoring software used for tracking and placement of single layer armor blocks used in breakwater construction; and 4G Underwater Survey Explorer that provides real-time visualization and automation processing for sonar software. Further, the company provides engineering services and embedded solutions, such as mission computers to prime defense contractors; and Thermite rugged visual computers, subsea telemetry and data acquisition systems, rugged workstations, analog-to-digital converters, and rugged LCD displays. It markets its products under the CodaOctopus brand name. Coda Octopus Group, Inc. was founded in 1994 and is headquartered in Orlando, Florida.
Earnings Per Share
As for profitability, Coda Octopus Group has a trailing twelve months EPS of $0.38.
PE Ratio
Coda Octopus Group has a trailing twelve months price to earnings ratio of 18.53. Meaning, the purchaser of the share is investing $18.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
4. Fifth Third Bancorp (FITB)
14.6% sales growth and 12.37% return on equity
Fifth Third is a bank that's as long on innovation as it is on history. Since 1858, we've been helping individuals, families, businesses and communities grow through smart financial services that improve lives. Our list of firsts is extensive, and it's one that continues to expand as we explore the intersection of tech-driven innovation, dedicated people, and focused community impact. Fifth Third is one of the few U.S.-based banks to have been named among Ethisphere's World's Most Ethical Companies® for several years. With a commitment to taking care of our customers, employees, communities and shareholders, our goal is not only to be the nation's highest performing regional bank, but to be the bank people most value and trust. Fifth Third Bank, National Association is a federally chartered institution. Fifth Third Bancorp is the indirect parent company of Fifth Third Bank and its common stock is traded on the NASDAQ® Global Select Market under the symbol “FITB.” Investor information and press releases can be viewed at www.53.com.
Earnings Per Share
As for profitability, Fifth Third Bancorp has a trailing twelve months EPS of $2.72.
PE Ratio
Fifth Third Bancorp has a trailing twelve months price to earnings ratio of 11.66. Meaning, the purchaser of the share is investing $11.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.37%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 28, 2022, the estimated forward annual dividend rate is 1.32 and the estimated forward annual dividend yield is 3.54%.
Moving Average
Fifth Third Bancorp’s worth is under its 50-day moving average of $35.22 and below its 200-day moving average of $34.92.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 26.2% and 26.3%, respectively.
Sales Growth
Fifth Third Bancorp’s sales growth is 19.3% for the ongoing quarter and 14.6% for the next.
Previous days news about Fifth Third Bancorp(FITB)
- According to CNBC on Tuesday, 7 March, "Truist Financial, Zions Bancorporation, Fifth Third Bancorp and Wells Fargo all dropped more than 3.5%."
5. Spirit Realty Capital (SRC)
11% sales growth and 6.22% return on equity
Spirit Realty Capital, Inc. (NYSE: SRC) is a premier net-lease REIT that primarily invests in single-tenant, operationally essential real estate assets, subject to long-term leases. As of September 30, 2020, our diverse portfolio of 1,778 owned properties, with an aggregate leasable area of 37.2 million square feet in 48 states, included retail, industrial and office buildings leased to 296 tenants across 28 retail industries.
Earnings Per Share
As for profitability, Spirit Realty Capital has a trailing twelve months EPS of $0.15.
PE Ratio
Spirit Realty Capital has a trailing twelve months price to earnings ratio of 290.63. Meaning, the purchaser of the share is investing $290.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.22%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.9%, now sitting on 682.27M for the twelve trailing months.
Yearly Top and Bottom Value
Spirit Realty Capital’s stock is valued at $43.60 at 05:22 EST, below its 52-week high of $48.24 and way higher than its 52-week low of $34.31.
6. Charles River Laboratories (CRL)
7.3% sales growth and 17.26% return on equity
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Earnings Per Share
As for profitability, Charles River Laboratories has a trailing twelve months EPS of $7.2.
PE Ratio
Charles River Laboratories has a trailing twelve months price to earnings ratio of 29.94. Meaning, the purchaser of the share is investing $29.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.26%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.4%, now sitting on 3.78B for the twelve trailing months.
Sales Growth
Charles River Laboratories’s sales growth is 14.4% for the current quarter and 7.3% for the next.
Volume
Today’s last reported volume for Charles River Laboratories is 376826 which is 34.45% below its average volume of 574893.
